Industry Symposia
GSK Lunchtime Symposium
Monday 23 February | 12:30pm - 1:30pm
Evolving EGPA Care: Translating Emerging Evidence into Clinical Practice
Pravin Hissaria, Benjamin Terrier, Roberto Padoan
CSL Lunchtime Symposium
Tuesday 24 February | 12:30pm - 1:30pm
New Horizons for the management of ANCA-associated Vasculitis
Professor David Jayne, Professor Onno Teng, Professor Karuna Keat
AbbVie Lunchtime Symposium
Wednesday 25 February | 12:40pm - 1:30pm
Rethinking Giant Cell Arteritis Care: Exploring individualised strategies targeting remission and glucocorticoid-free outcomes
Christian Dejaco, Claire Owen
Breakfast Sessions
Breakfast Session
Monday 23 February | 7:50am - 8:50am
The striking overlap between IgG4 related disease and the ANCA-associated vasculitides
John Stone
Scientifically and educationally independent IgG4-RD/AAV session, breakfast sponsored by Amgen.
Breakfast Session
Tuesday 24 February | 7:50am - 8:50am
When should treatment for ANCA-associated vasculitis be discontinued?
Peter Merkel
Scientifically and educationally independent AAV session, breakfast sponsored by Alexion.
Enquiries
Please direct all enquiries to the Workshop Secretariat:
IVW 2026 Secretariat
P: 03 9682 0500E: registration@vasculitis-melbourne2026.com





